Comet assay: A method to evaluate genotoxicity of nano-drug delivery system

BioImpacts

Volumn 1, Issue 2, 2011, Pages 87-97

  Vandghanooni, Somayeh ^a   Eskandani, Morteza ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Comet assay; DNA; Drug delivery; Genotoxicity; Nanoparticle; Single cell gel electrophoresis

Indexed keywords

CARBON BLACK; NANOPARTICLE; SILICON DIOXIDE; SINGLE WALLED NANOTUBE; SODIUM CHLORIDE; TITANIUM DIOXIDE; UNCLASSIFIED DRUG; ZINC OXIDE;

ALKALINITY; APOPTOSIS; COMET ASSAY; CYTOLYSIS; DNA DAMAGE; DNA FRAGMENTATION; DNA STRAND BREAKAGE; DNA SUPERCOILING; DRUG DELIVERY SYSTEM; DRUG RESEARCH; GENOTOXICITY; MATERIALS TESTING; NANO DRUG DELIVERY SYSTEM; NANOPHARMACEUTICS; NANOTOXICOLOGY; REVIEW; TOXICITY TESTING;

EID: 84874697767     PISSN: 22285652     EISSN: 22285660     Source Type: Journal    
DOI: 10.5681/bi.2011.012     Document Type: Review

References (79)

1. Arayne Ms, Sultana N and Qureshi F. 2007. Review: nanoparticles in delivery of cardiovascular drugs. Pak J Pharm Sci, 20(4), 340-8.
2. Aschberger K, Johnston Hj, Stone V, Aitken Rj, Tran Cl, Hankin Sm, et al.2010. Review of fullerene toxicity and exposure--appraisal of a human health risk assessment, based on open literature. Regul Toxicol Pharmacol, 58(3), 455-73.
3. Barnes Ca, Elsaesser A, Arkusz J, Smok A, Palus J, Lesniak A, et al.2008. Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity. Nano Lett, 8(9), 3069-74.
4. Beaux Mf, 2nd, Mcilroy Dn and Gustin Ke. 2008. Utilization of solid nanomaterials for drug delivery. Expert Opin Drug Deliv, 5(7), 725-35.
5. Boussif O, Lezoualc'h F, Zanta Ma, Mergny Md, Scherman D, Demeneix B, et al.1995. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A, 92(16), 7297-301.
6. Cakmak Gd, Schins Rp, Shi T, Fenoglio I, Fubini B and Borm Pj. 2004. In vitro genotoxicity assessment of commercial quartz flours in comparison to standard DQ12 quartz. Int J Hyg Environ Health, 207(2), 105-13.
7. Calvo P, Remunan-Lopez C, Vila-Jato Jl and Alonso Mj. 1997. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res, 14(10), 1431-6.
8. Chakravarty P, Qian W, El-Sayed Ma and Prausnitz Mr. 2010. Delivery of molecules into cells using carbon nanoparticles activated by femtosecond laser pulses. Nat Nanotechnol, 5(8), 607-11.
9. Chen X, Tam Uc, Czlapinski Jl, Lee Gs, Rabuka D, Zettl A, et al.2006. Interfacing carbon nanotubes with living cells. J Am Chem Soc, 128(19), 6292-3.
10. Cheng Md. 2004. Effects of nanophase materials (< or = 20 nm) on biological responses. J Environ Sci Health A Tox Hazard Subst Environ Eng, 39(10), 2691-705.
11. Chung Ddl. 2004. Electrical applications of carbon materials. Journal of Materials Science, 39(8), 2645-2661.
12. Demeneix B, Behr J, Boussif O, Zanta Ma, Abdallah B and Remy J. 1998. Gene transfer with lipospermines and polyethylenimines. Adv Drug Deliv Rev, 30(1-3), 85-95.
13. Dhawan A and Sharma V. 2010. Toxicity assessment of nanomaterials: methods and challenges. Anal Bioanal Chem, 398(2), 589-605.
14. Dhawan A, Taurozzi Js, Pandey Ak, Shan W, Miller Sm, Hashsham Sa, et al.2006. Stable colloidal dispersions of C60 fullerenes in water: evidence for genotoxicity. Environ Sci Technol, 40(23), 7394-401.
15. Dolatabadi JE, Mashinchian O, Ayoubi B, Jamali Aa, Mobed A, Losic D, et al.2011. Optical and electrochemical DNA nanobiosensors. TrAC Trends in Analytical Chemistry, 30(3), 459-472.
16. Donner M, Tran L, Muller J and Vrijhof H. 2010. Genotoxicity of engineered nanomaterials. Nanotoxicology, 4345-6.
17. Dunford R, Salinaro A, Cai L, Serpone N, Horikoshi S, Hidaka H, et al.1997. Chemical oxidation and DNA damage catalysed by inorganic sunscreen ingredients. FEBS Lett, 418(1-2), 87- 90.
18. Efentakis M, Pagoni I, Vlachou M and Avgoustakis K. 2007. Dimensional changes, gel layer evolution and drug release studies in hydrophilic matrices loaded with drugs of different solubility. Int J Pharm, 339(1-2), 66-75.
19. El-Aneed A. 2004. An overview of current delivery systems in cancer gene therapy. J Control Release 941-14.
20. Elouahabi A and Ruysschaert Jm. 2005. Formation and intracellular trafficking of lipoplexes and polyplexes. Mol Ther, 11(3), 336-47.
21. Eskandani M, Golchai J, Pirooznia N and Hasannia S. 2010. Oxidative stress level and tyrosinase activity in vitiligo patients. Indian J Dermatol, 55(1), 15-9.
22. Fitzgerald Mg and Hosking Cs. 1982. Cell structure and percent viability by a slide centrifuge technique. J Clin Pathol, 35(2), 191-4.
23. Frank A, Rath Sk and Venkatraman Ss. 2005. Controlled release from bioerodible polymers: effect of drug type and polymer composition. J Control Release, 102(2), 333-44.
24. Fubini B, Ghiazza M and Fenoglio I. 2010. Physico-chemical features of engineered nanoparticles relevant to their toxicity. Nanotoxicology, 4347-63.
25. Gao H and Hui Km. 2001. Synthesis of a novel series of cationic lipids that can act as efficient gene delivery vehicles through systematic heterocyclic substitution of cholesterol derivatives. Gene Ther, 8(11), 855-63.
26. Gopalan Rc, Osman If, Amani A, De Matas M and Anderson D. 2009. The effect of zinc oxide and titanium dioxide nanoparticles in the Comet assay with UVA photoactivation of human sperm and lymphocytes. Nanotoxicology, 3(1), 33-39.
27. Greenberg Mi, Waksman J and Curtis J. 2007. Silicosis: a review. Dis Mon, 53(8), 394-416.
28. Gurr Jr, Wang As, Chen Ch and Jan Ky. 2005. Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells. Toxicology, 213(1-2), 66-73.
29. Hammond Pt. 2011. Virtual issue on nanomaterials for drug delivery. ACS Nano, 5(2), 681-4.
30. He Q, Shi J, Chen F, Zhu M and Zhang L. 2010. An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticles. Biomaterials, 31(12), 3335- 46.
31. Hoeijmakers Jh. 2001. Genome maintenance mechanisms for preventing cancer. Nature, 411(6835), 366-74.
32. Hoshino A, Fujioka K, Oku T, Suga M, Sasaki Yf, Ohta T, et al.2004. Physicochemical Properties and Cellular Toxicity of Nanocrystal Quantum Dots Depend on Their Surface Modification. Nano Letters, 4(11), 2163-2169.
33. Jacobsen Nr, Pojana G, White P, Moller P, Cohn Ca, Korsholm Ks, et al.2008. Genotoxicity, cytotoxicity, and reactive oxygen species induced by single-walled carbon nanotubes and C(60) fullerenes in the FE1-Mutatrade markMouse lung epithelial cells. Environ Mol Mutagen, 49(6), 476-87.
34. Jacobsen Nr, Saber At, White P, Moller P, Pojana G, Vogel U, et al.2007. Increased mutant frequency by carbon black, but not quartz, in the lacZ and cII transgenes of muta mouse lung epithelial cells. Environ Mol Mutagen, 48(6), 451-61.
35. Jang J, Lim Dh and Choi Ih. 2010. The impact of nanomaterials in immune system. Immune Netw, 10(3), 85-91.
36. Ji Sr, Liu C, Zhang B, Yang F, Xu J, Long J, et al.2010. Carbon nanotubes in cancer diagnosis and therapy. Biochim Biophys Acta, 1806(1), 29-35.
37. Jin Y, Kannan S, Wu M and Zhao Jx. 2007. Toxicity of luminescent silica nanoparticles to living cells. Chem Res Toxicol, 20(8), 1126-33.
38. Jones Cf and Grainger Dw. 2009. In vitro assessments of nanomaterial toxicity. Adv Drug Deliv Rev, 61(6), 438-56.
39. Kafil V and Omidi Y. 2011. Cytotoxic impacts of linear and branched polyethylenimine nanostructures in A431 cells. BioImpacts, 1(1), 23-30.
40. Karlsson Hl. 2010. The comet assay in nanotoxicology research. Anal Bioanal Chem, 398(2), 651-66.
41. Karlsson Hl, Cronholm P, Gustafsson J and Moller L. 2008. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol, 21(9), 1726-32.
42. Kisin Er, Murray Ar, Keane Mj, Shi Xc, Schwegler-Berry D, Gorelik O, et al.2007. Single-walled carbon nanotubes: genoand cytotoxic effects in lung fibroblast V79 cells. J Toxicol Environ Health A, 70(24), 2071-9.
43. Kokubo T, Kim Hm and Kawashita M. 2003. Novel bioactive materials with different mechanical properties. Biomaterials, 24(13), 2161-75.
44. Landsiedel R, Ma-Hock L, Van Ravenzwaay B, Schulz M, Wiench K, Champ S, et al.2010. Gene toxicity studies on titanium dioxide and zinc oxide nanomaterials used for UVprotection in cosmetic formulations. Nanotoxicology, 4364-81.
45. Li S and Liu X. 2004. [Development of polymeric nanoparticles in the targeting drugs carriers]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 21(3), 495-7.
46. Mckenna Dj, Mckeown Sr and Mckelvey-Martin Vj. 2008. Potential use of the comet assay in the clinical management of cancer. Mutagenesis, 23(3), 183-90.
47. Mroz Rm, Schins Rp, Li H, Jimenez La, Drost Em, Holownia A, et al.2008. Nanoparticle-driven DNA damage mimics irradiation-related carcinogenesis pathways. Eur Respir J, 31(2), 241-51.
48. Nadin Sb, Vargas-Roig Lm and Ciocca Dr. 2001. A silver staining method for single-cell gel assay. J Histochem Cytochem, 49(9), 1183-6.
49. Nakagawa Y, Wakuri S, Sakamoto K and Tanaka N. 1997. The photogenotoxicity of titanium dioxide particles. Mutat Res, 394(1-3), 125-32.
50. Neubauer O, Reichhold S, Nersesyan A, Konig D and Wagner Kh. 2008. Exercise-induced DNA damage: is there a relationship with inflammatory responses? Exerc Immunol Rev, 1451-72.
51. Olive Pl, Banath Jp and Durand Re. 1990a. Detection of etoposide resistance by measuring DNA damage in individual Chinese hamster cells. J Natl Cancer Inst, 82(9), 779-83.
52. Olive Pl, Banath Jp and Durand Re. 1990b. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay. Radiat Res, 122(1), 86-94.
53. Omidi Y, Barar J, Heidari Hr, Ahmadian S, Yazdi Ha and Akhtar S. 2008. Microarray analysis of the toxicogenomics and the genotoxic potential of a cationic lipid-based gene delivery nanosystem in human alveolar epithelial a549 cells. Toxicol Mech Methods, 18(4), 369-78.
54. Ostling O and Johanson Kj. 1984. Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem Biophys Res Commun, 123(1), 291-8.
55. Owens De, 3rd and Peppas Na. 2006. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm, 307(1), 93-102.
56. Pacheco S, Mashayekhi H, Jiang W, Xing B and Arcaro Kf. 2007. DNA damaging effects of nanoparticles in breast cancer cells. Abstracts of the Annual Meeting of the American Association for Cancer Research.
57. Park Ej and Park K. 2009. Oxidative stress and proinflammatory responses induced by silica nanoparticles in vivo and in vitro. Toxicol Lett, 184(1), 18-25.
58. Petros Ra and Desimone Jm. 2010. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov, 9(8), 615-27.
59. Phillips Dh and Arlt Vm. 2009. Genotoxicity: damage to DNA and its consequences. EXS, 9987-110.
60. Plumb Ja. 2004. Cell sensitivity assays: the MTT assay. Methods Mol Med, 88165-9.
61. Pramod P, Thomas Kg and George Mv. 2009. Organic nanomaterials: morphological control for charge stabilization and charge transport. Chem Asian J, 4(6), 806-23.
62. Reddy Ar, Reddy Yn, Krishna Dr and Himabindu V. 2010. Multi wall carbon nanotubes induce oxidative stress and cytotoxicity in human embryonic kidney (HEK293) cells. Toxicology, 272(1-3), 11-6.
63. Rojas E, Lopez Mc and Valverde M. 1999. Single cell gel electrophoresis assay: methodology and applications. J Chromatogr B Biomed Sci Appl, 722(1-2), 225-54.
64. Sanjinés R, Abad Md, Vâju C, Smajda R, Mionic M and Magrez A. Electrical properties and applications of carbon based nanocomposite materials: An overview. Surface and Coatings Technology, In Press, Corrected Proof.
65. Signoretto M, Ghedini E, Nichele V, Pinna F, Crocellà V and Cerrato G.
66. Singh N, Manshian B, Jenkins Gj, Griffiths Sm, Williams Pm, Maffeis Tg, et al.2009. NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials, 30(23-24), 3891-914.
67. Singh Np, Mccoy Mt, Tice Rr and Schneider El. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res, 175(1), 184-91.
68. Sohaebuddin Sk, Thevenot Pt, Baker D, Eaton Jw and Tang L. 2010. Nanomaterial cytotoxicity is composition, size, and cell type dependent. Part Fibre Toxicol, 722.
69. Stoddart Mj. 2011. Cell viability assays: introduction. Methods Mol Biol, 7401-6.
70. Supino R. 1995. MTT assays. Methods Mol Biol, 43137-49.
71. Suri Ss, Fenniri H and Singh B. 2007. Nanotechnology-based drug delivery systems. J Occup Med Toxicol, 216.
72. Wang C, Guo Z-X, Fu S, Wu W and Zhu D. 2004. Polymers containing fullerene or carbon nanotube structures. Progress in Polymer Science, 29(11), 1079-1141.
73. Wang Jj, Sanderson Bj and Wang H. 2007. Cyto- and genotoxicity of ultrafine TiO2 particles in cultured human lymphoblastoid cells. Mutat Res, 628(2), 99-106.
74. Warheit Db and Donner Em. 2010. Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines. Nanotoxicology, 4409-13.
75. West Jl and Halas Nj. 2003. Engineered nanomaterials for biophotonics applications: improving sensing, imaging, and therapeutics. Annu Rev Biomed Eng, 5285-92.
76. Yang L and Webster Tj. 2009. Nanotechnology controlled drug delivery for treating bone diseases. Expert Opin Drug Deliv, 6(8), 851-64.
77. Zhang M, Yang Z, Chow Ll and Wang Ch. 2003. Simulation of drug release from biodegradable polymeric microspheres with bulk and surface erosions. J Pharm Sci, 92(10), 2040-56.
78. Zhong Bz, Whong Wz and Ong Tm. 1997. Detection of mineral-dust-induced DNA damage in two mammalian cell lines using the alkaline single cell gel/comet assay. Mutat Res, 393(3), 181-7.
79. Zhu Y, Fang Y, Borchardt L and Kaskel S. 2011. PEGylated hollow mesoporous silica nanoparticles as potential drug delivery vehicles. Microporous and Mesoporous Materials, 141(1-3), 199-206.